What is Addgene?
Operating as a centralized hub for the scientific community, Addgene manages a sophisticated repository of plasmids, pooled libraries, and viral services including AAV and lentivirus. The organization effectively bridges the gap between academic discovery and industrial application by streamlining the complex processes of Material Transfer Agreements and intellectual property protection. Through its managed repository model, Addgene ensures that high-quality research tools are accessible to scientists worldwide, thereby accelerating the pace of innovation in biotechnology and molecular biology. Its commitment to technology transfer and open scientific sharing has made it an indispensable partner for both academic institutions and commercial entities.
How much funding has Addgene raised?
Addgene has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Addgene
PPP
Public-Private Partnership
What's next for Addgene?
With this major enterprise-level funding, Addgene is well-positioned to scale its operational capacity and expand its catalog of biological resources. The organization is expected to leverage this capital to enhance its digital infrastructure, improve the efficiency of its viral vector production, and broaden its outreach to emerging research markets. As the demand for standardized, high-quality research materials continues to rise, Addgene's strategic focus will likely remain on optimizing its distribution network and strengthening its role as a facilitator of global scientific collaboration. This financial backing provides the necessary runway to sustain its mission-driven growth while maintaining the rigorous standards required by the life sciences sector.
See full Addgene company page
